Net profit of Supriya Lifescience rose 36.42% to Rs 50.38 crore in the quarter ended March 2025 as against Rs 36.93 crore during the previous quarter ended March 2024. Sales rose 16.39% to Rs 184.11 crore in the quarter ended March 2025 as against Rs 158.18 crore during the previous quarter ended March 2024.
For the full year,net profit rose 57.80% to Rs 187.96 crore in the year ended March 2025 as against Rs 119.11 crore during the previous year ended March 2024. Sales rose 22.11% to Rs 696.49 crore in the year ended March 2025 as against Rs 570.37 crore during the previous year ended March 2024.
| Particulars | Quarter Ended | Year Ended |
| Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. |
| Sales | 184.11 | 158.18 | 16 | 696.49 | 570.37 | 22 |
| OPM % | 36.71 | 35.08 | - | 37.44 | 30.33 | - |
| PBDT | 70.14 | 57.08 | 23 | 268.93 | 181.50 | 48 |
| PBT | 64.06 | 53.17 | 20 | 248.49 | 165.69 | 50 |
| NP | 50.38 | 36.93 | 36 | 187.96 | 119.11 | 58 |